Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28081882)
Watch
English
PD-1 and PD-L1 antibodies for melanoma
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
PD-1 and PD-L1 antibodies for melanoma
(English)
1 reference
stated in
PubMed
main subject
antibody
1 reference
based on heuristic
inferred from title
author
Adil Daud
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
author name string
Katy K Tsai
series ordinal
1
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
Inés Zarzoso
series ordinal
2
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
2014
1 reference
stated in
PubMed
published in
Human Vaccines & Immunotherapeutics
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
volume
10
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
issue
11
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
page(s)
3111-3116
1 reference
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
cites work
Nivolumab plus ipilimumab in advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Tumor microenvironments, the immune system and cancer survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
PD-1 and its ligands in tolerance and immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Expression of programmed death 1 ligands by murine T cells and APC
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
20 March 2017
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
7 April 2017
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
7 April 2017
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
7 April 2017
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
Oncology meets immunology: the cancer-immunity cycle
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
The B7-CD28 superfamily
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
29 September 2017
Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4161%2F21645515.2014.983409
retrieved
21 January 2018
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4161%2F21645515.2014.983409
retrieved
21 January 2018
Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4514131
retrieved
27 November 2018
Studies on the two-signal model for T cell activation in vivo
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25625924
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25625924
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.4161/21645515.2014.983409
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
PMC publication ID
4514131
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
PubMed publication ID
25625924
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4514131
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25625924%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 June 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit